pylori

HPi1 是一种有口服活性的，针对幽门螺杆菌的选择性抗菌剂，IC50为 0.24 μM，MIC 为 0.08-0.16 μg mL。

Rabeprazole Sulfide (Rabeprazole Related Compound E) 是 Rabeprazole 的活性代谢产物。Rabeprazole 是一种质子泵抑制剂类的抗溃疡药物，有效抑制幽门螺旋杆菌的活性，可通过与胃壁细胞中的(H+ K+)-ATPase 相互作用来抑制胃酸分泌，可研究各种消化系统疾病。

Bismuth Subcitrate Potassium 是一种对 12 种幽门螺杆菌有作用的抗生素，抑制组胺H2受体，可用于研究 SARS-CoV-2 感染脆弱患者的腹泻和消化性溃疡病。

WF 2421 is an aldose reductase inhibitor produced by Humicola grisea.

CV-6209 是一种具有选择性和高效性的血小板活化因子 (PAF) 拮抗剂，具有抗增殖作用，部分抑制乙酰胆碱诱导的低血压，抑制 Paf 诱导的 PMN 或血小板聚集。CV-6209 具有抗幽门螺杆菌作用，可以抑制 PAF 引起的大鼠低血压。

Rebamipide (OPC12759) 是一种粘膜保护剂，可诱导COX-2表达，增加PGE2水平，并以 COX-2 依赖性方式增强胃粘膜防御。

Octyl gallate (Octyl 3,4,5-trihydroxybenzoate) 具有抗菌、抗氧化作用，有选择性和敏感性的荧光特性，广泛用作食品添加剂。它对 HSV-1，水泡性口炎病毒和脊髓灰质炎病毒有显著的抗病毒作用。

pNNP (Nitrophenylphosphate) 可用作 PP2C 试验的底物。pNNP 对β-碳酸酐酶和α-碳酸酯脱水酶有抑制作用，对幽门螺杆菌幽门螺杆菌也具有抑制作用。pNNP 是一种活性较弱的组织非特异性碱性磷酸酶调节剂。

L-Glutamic acid monosodium salt monohydrate （MSG monohydrate）是一种重要的食品添加剂，具有胃肠道保护作用，在营养代谢、能量需求、免疫响应、氧化应激、信号通路调节及突触传递中有重要作用。L-Glutamic acid monosodium salt monohydrate 诱导小鼠肝脏和脑组织氧化应激、DNA损伤和细胞凋亡。L-Glutamic acid monosodium salt monohydrate 可通过多种机制保护非甾体抗炎药及幽门螺杆菌引起的胃肠道损伤。

Finafloxacin, a fluoroquinolone antimicrobial agent from a new 8-cyano subclass, is most effective in slightly acidic environments (pH 5.0-6.0), a condition where other fluoroquinolones typically reduce in activity. It selectively targets bacterial type II topoisomerases, such as DNA gyrase and DNA topoisomerase IV, making it suitable for treating serious bacterial infections particularly in acidic contexts, including urinary tract infections (UTIs) and Helicobacter pylori infections.

Xinjiachalcone A is a natural product isolated from Glycyrrhiza inflata Batalin. Xinjiachalcone A shows both a low MIC and a strong bactericidal activity against H. pylori(MIC : 12.5 to 50 µM, seventeen H. pylori strains).

FR-145715 作为一种组胺H2受体拮抗剂，展现出针对幽门螺杆菌的特异性抗菌活性，常用于研究胃部病变。

4-Hexen-3-one 对 ATCC 43526 菌株和 TDR 菌株的 H. pylori 生长展示了明显的抑制作用，并抑制了尿素酶的活性。

VPC162134 是一种抗菌剂，能够抑制H. pylori、C. jejuni、MRSA和S. epidermidis，最低抑制浓度（MIC）分别为2.9、17.5、93.3和93.3 μM。此外，VPC162134 是丙酮酸铁氧还蛋白氧化还原酶 (PFOR) 的抑制剂。

JAK05 对 Helicobacter pylori 具有抑制活性，能抑制 J63、J196 和 J107 菌株，其最低抑制浓度（MIC）为 3-5 µg mL。JAK05 对 H+ K+-ATPase、COX-1 2、TNF-α 和 PGE2 具有结合亲和力，具备抗氧化及抗炎特性。该化合物在大鼠乙醇诱发的胃溃疡模型中显示出抗溃疡活性。

BAS-118 是一种具有抗菌活性的苯酰胺衍生物。在对 100 株随机选择的幽门螺杆菌(Helicobacter pylori) 分离株的测试中，其MIC50、MIC90和MIC范围分别为 ≤0.003、0.013 和 ≤0.003-0.025 mg L。BAS-118 有潜力用于抗H. pylori剂的研究。

Urease-IN-20 (compound XBP2) 是一种针对 Helicobacter pylori (H. pylori) 的抑制剂，具有 0.14 μM 的 IC50。在感染 H. pylori 的 GES-1 细胞中，Urease-IN-20 能减少细胞凋亡 (Apoptosis) 和降低 ROS 与 γH2AX 的水平。它展示了显著的胃黏膜保护作用，适用于幽门螺杆菌研究。

Clovamide (trans-Clovamide) 是一种天然存在的咖啡酰结合物，具有抗菌、抗炎、抗氧化和神经保护作用。它是一种极好的活性氧和氧自由基清除剂。

FR-182024 is a novel cephem derivative, it has potent anti-Helicobacter pylori activity.

FR-193879 is an efficacious cephem derivative, it has extremely potent therapeutic efficacy against H. pylori.

MDK-4624 is a AMPKα1 activator. MDK-4624 inhibits Helicobacter pylori-induced oxidative stresses and gastric epithelial cell apoptosis. MDK-4624 attenuates dexamethasone-induced osteoblast cell death. MDK-4624 potently inhibits melanoma cell proliferation

Spirolaxine, a natural product isolated from Sporotrichum laxum ATCC 15155, has shown a variety of biological activities including promising anti-Helicobacter pylori property.

4-Amino-6-chloro-1,3-benzenedisulfonamide is a carbonic anhydrase inhibitor.1 Formulations containing this compound are diuretics.2 4-Amino-6-chloro-1,3-benzenedisulfonamide is detected as a hydrolysis product of chlorothiazide in the urine.2 Diuretics, including chlorothiazide, have been abused as performance-enhancing drugs and masking agents in sports doping.3References1. Nishimori, I., Vullo, D., Minakuchi, T., et al. Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori. Bioorg. Med. Chem. Lett. 16(8), 2182-2188 (2006).2. Deventer, K., Pozo, O.J., Van Eenoo, P., et al. Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. J. Chromatogr. A 1216(12), 2466-2473 (2009).3. Cadwallader, A.B., de la Torre, X., Tieri, A., et al. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: Pharmacology, toxicology and analysis. Br. J. Pharmacol. 161(1), 1-16 (2010). 4-Amino-6-chloro-1,3-benzenedisulfonamide is a carbonic anhydrase inhibitor.1 Formulations containing this compound are diuretics.2 4-Amino-6-chloro-1,3-benzenedisulfonamide is detected as a hydrolysis product of chlorothiazide in the urine.2 Diuretics, including chlorothiazide, have been abused as performance-enhancing drugs and masking agents in sports doping.3 References1. Nishimori, I., Vullo, D., Minakuchi, T., et al. Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori. Bioorg. Med. Chem. Lett. 16(8), 2182-2188 (2006).2. Deventer, K., Pozo, O.J., Van Eenoo, P., et al. Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. J. Chromatogr. A 1216(12), 2466-2473 (2009).3. Cadwallader, A.B., de la Torre, X., Tieri, A., et al. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: Pharmacology, toxicology and analysis. Br. J. Pharmacol. 161(1), 1-16 (2010).

Actinopyrone A is a pyrone isolated from S. pactum with diverse biological activities. It has selective and potent antimicrobial activity against H. pylori (MIC = 0.1 ng mL) with no activity against other Gram-negative bacteria including E. coli, K. pneumoniae, P. aeruginosa, and B. fragilis. Actinopyrone A also mildly inhibits growth of Gram-positive bacteria and dermatophytes with MIC values ranging from <6.25 to 25 μg mL. Intravenous administration of actinopyrone A (30 μg kg) increases coronary blood flow in dogs by 196.2%.